Evidence map›Paper›PMID 29528566›Full record

ArticlePediatric pulmonology2018

Difficult conversations: Discussing prognosis with children with cystic fibrosis.

Julia Gray Farber, Mary G Prieur, Christine Roach, Rosemary Shay, Michelle Walter, Drucy Borowitz, Elisabeth P Dellon

Abstract read
In one paragraph

Article in Pediatric pulmonology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.6field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Julia Gray FarberUniversity of North Carolina School of Medicine, Chapel Hill, North Carolina.
Mary G PrieurDepartments of Psychiatry and Pediatrics, University of North Carolina School of Medicine, Chapel Hill, North Carolina.
Christine RoachDepartment of Pediatrics, Jacobs School of Medicine, University at Buffalo of State University of New York, Buffalo, New York.
Rosemary ShayUniversity of North Carolina School of Medicine, Chapel Hill, North Carolina.
Michelle WalterDepartment of Geriatrics and Palliative Medicine, Jacobs School of Medicine, University at Buffalo of State University of New York, Buffalo, New York.
Drucy BorowitzDepartment of Pediatrics, Jacobs School of Medicine, University at Buffalo of State University of New York, Buffalo, New York.
Elisabeth P DellonDivision of Pulmonology, Department of Pediatrics, University of North Carolina School of Medicine, Chapel Hill, North Carolina.ORCID 0000-0003-3794-6329
University of North Carolina at Chapel Hill · USUniversity at Buffalo, State University of New York · USCystic Fibrosis Foundation · US

Funding

SHORT-TERM RESEARCH TRAININGT35DK007386 · NIDDK · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Evan Samuel Dellon · 1986 to 2026
$4.1M
NIDDK NIH HHS T35 DK007386
6 · The paper itself

Abstract

Background Despite the chronic, progressive, and life-threatening nature of cystic fibrosis (CF), there are no guidelines for when and how to communicate prognosis to children with CF.

methodsSemi-structured interviews with young adults with CF, parents of young adults with CF, and multidisciplinary CF health care providers assessed recall of and practices for communicating about prognosis. Recommendations for improvements were also solicited.

resultsYoung adults with CF recalled learning that life expectancy is limited by CF between the ages of 8 and 16 years, and that CF is a progressive disease between the ages of 7 and 19 years. They reported that the information often came from CF physicians or from online resources. Patients and parents reported earlier knowledge of prognosis than providers assumed. While learning about prognosis caused sadness and stress for some patients and families, others denied negative feelings. Interestingly, most patients reported that disclosure of prognosis had minimal impact on their adherence and treatment goals. Patients and parents reported wanting physicians to be involved in conversations about prognosis. However, providers noted several barriers to discussing prognosis, including their own reluctance, time limitations, and uncertainty about appropriate timing and content of communication.

conclusionsCommunication about prognosis is important but also difficult for providers, patients, and families. Appropriately timed conversations, using tools to facilitate communication, could ensure patients receive timely, accurate information.

Indexed as

Health CommunicationAdolescentAdultCystic FibrosisFemaleHumansMaleParentsPhysiciansPrognosisYoung Adultcommunicationcystic fibrosisprognosis

Identifiers

PMID29528566
PMCPMC5904004
OpenAlexW2791210839

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.